Evidence map›Paper›PMID 37047478›Full record

ReviewInternational journal of molecular sciences2023

Role of Muscarinic Acetylcholine Receptors in Intestinal Epithelial Homeostasis: Insights for the Treatment of Inflammatory Bowel Disease.

Junsuke Uwada, Hitomi Nakazawa, Ikunobu Muramatsu, Takayoshi Masuoka, Takashi Yazawa

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Selective modulation of murine intestinal MAmerican journal of physiology. Cell physiology · 2026
    Article
  12. Article
  13. Review
  14. Intestinal-related substances in obesity regulation: A comprehensive review.World journal of gastrointestinal pharmacology and therapeutics · 2025
    Review
  15. NSAIDs beyond COX:ACS omega · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Junsuke UwadaDepartment of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada 920-0293, Japan.ORCID 0000-0002-6123-9061
Hitomi NakazawaDepartment of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada 920-0293, Japan.
Ikunobu MuramatsuDepartment of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada 920-0293, Japan.
Takayoshi MasuokaDepartment of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada 920-0293, Japan.
Takashi YazawaDepartment of Biochemistry, Asahikawa Medical University, Asahikawa 078-8510, Japan.
Kanazawa Medical University · JPAsahikawa Medical University · JPUniversity of Fukui · JP

Funding

Akiyama Life Science Foundation 141-032Japan Society for the Promotion of Science 19K09794, 22K07358, 22K06637Kobayashi Pharmaceutical (Japan) no.181The Grant of National Center for Child Health and Development 2021-A1The Smoking Research Foundation of Japan 2021G008, 2020G006
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is an intestinal disorder that causes prolonged inflammation of the gastrointestinal tract. Currently, the etiology of IBD is not fully understood and treatments are insufficient to completely cure the disease. In addition to absorbing essential nutrients, intestinal epithelial cells prevent the entry of foreign antigens (micro-organisms and undigested food) through mucus secretion and epithelial barrier formation. Disruption of the intestinal epithelial homeostasis exacerbates inflammation. Thus, the maintenance and reinforcement of epithelial function may have therapeutic benefits in the treatment of IBD. Muscarinic acetylcholine receptors (mAChRs) are G protein-coupled receptors for acetylcholine that are expressed in intestinal epithelial cells. Recent studies have revealed the role of mAChRs in the maintenance of intestinal epithelial homeostasis. The importance of non-neuronal acetylcholine in mAChR activation in epithelial cells has also been recognized. This review aimed to summarize recent advances in research on mAChRs for intestinal epithelial homeostasis and the involvement of non-neuronal acetylcholine systems, and highlight their potential as targets for IBD therapy.

Indexed as

Inflammatory Bowel DiseasesIntestinal MucosaAcetylcholineHomeostasisHumansInflammationReceptors, MuscarinicAcetylcholineReceptors, Muscarinicacetylcholineepithelial barrierhomeostasisinflammatory bowel diseasemuscarinic receptornon-neuronal acetylcholine

Identifiers

PMID37047478
PMCPMC10095461
OpenAlexW4362471755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.